SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010795
Filing Date
2019-11-12
Accepted
2019-11-12 16:01:35
Documents
70
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atre-20190930x10q.htm 10-Q 2643991
2 EX-10.3 atre-20190930ex1033f43aa.htm EX-10.3 11981
3 EX-31.1 atre-20190930ex3116b95fb.htm EX-31.1 10658
4 EX-31.2 atre-20190930ex312381640.htm EX-31.2 10586
5 EX-32.1 atre-20190930ex32109d97e.htm EX-32.1 10776
6 GRAPHIC atre20190930ex1033f43aa001.jpg GRAPHIC 6144
  Complete submission text file 0001558370-19-010795.txt   7553602

Data Files

Seq Description Document Type Size
7 EX-101.INS atre-20190930.xml EX-101.INS 1458799
8 EX-101.SCH atre-20190930.xsd EX-101.SCH 38528
9 EX-101.CAL atre-20190930_cal.xml EX-101.CAL 55518
10 EX-101.DEF atre-20190930_def.xml EX-101.DEF 190621
11 EX-101.LAB atre-20190930_lab.xml EX-101.LAB 353439
12 EX-101.PRE atre-20190930_pre.xml EX-101.PRE 329071
Mailing Address 500 SAGINAW DRIVE, FIRST FLOOR REDWOOD CITY CA 94063
Business Address 500 SAGINAW DRIVE, FIRST FLOOR REDWOOD CITY CA 94063 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38935 | Film No.: 191209181
SIC: 2834 Pharmaceutical Preparations